2019
Hyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1147-1153. DOI: 10.1007/978-3-319-74588-6_94.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cellsHyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1-7. DOI: 10.1007/978-3-319-74698-2_94-1.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cells
2007
Obesity, White Blood Cell Counts, and Platelet Counts among Police Officers
Charles LE, Fekedulegn D, McCall T, Burchfiel CM, Andrew ME, Violanti JM. Obesity, White Blood Cell Counts, and Platelet Counts among Police Officers. Obesity 2007, 15: 2846-2854. PMID: 18070777, DOI: 10.1038/oby.2007.338.Peer-Reviewed Original ResearchConceptsPlatelet countAbdominal heightWBC countWhite blood cell countHigher mean platelet countHigh WBC countMean platelet countBlood cell countComplete blood countCross-sectional studyT-testStudent's t-testCurrent smokersObesity indicesBlood countClinic staffHematologic parametersPhysical activityBlood samplesAnalysis of covarianceAnthropometric measuresCell countSignificant associationObesityWomen
2004
Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia
Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK. Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia. Cancer Research 2004, 64: 2000-2006. PMID: 15026336, DOI: 10.1158/0008-5472.can-03-2387.Peer-Reviewed Original ResearchMeSH KeywordsAcid Anhydride HydrolasesAdolescentAntimetabolites, AntineoplasticAzacitidineB-LymphocytesChildChild, PreschoolChromosomes, Human, Pair 12Chromosomes, Human, Pair 21CpG IslandsDecitabineDiploidyDNA MethylationDNA, NeoplasmFemaleGene DeletionGene Expression Regulation, NeoplasticHumansLeukemia, MyeloidMaleNeoplasm ProteinsPrecursor Cell Lymphoblastic Leukemia-LymphomaPromoter Regions, GeneticT-LymphocytesTranslocation, GeneticTumor Cells, CulturedConceptsPediatric leukemiaFHIT geneB cellsLeukemia cell linesFHIT methylation statusHigh WBC countPopulation-based casesChildhood leukemia patientsCell linesHyperdiploid B cellsHypermethylation of FHITPrognostic indicatorWBC countMethylation-specific PCRLeukemia patientsMyeloid leukemiaCytogenetic subtypesLoss of heterozygosityBone marrowFHIT expressionPrimary leukemiasFHIT inactivationFHIT methylationHuman malignanciesLeukemia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply